Correlation Between GeneReach Biotechnology and CHINA DEVELOPMENT
Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and CHINA DEVELOPMENT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and CHINA DEVELOPMENT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneReach Biotechnology and CHINA DEVELOPMENT FINANCIAL, you can compare the effects of market volatilities on GeneReach Biotechnology and CHINA DEVELOPMENT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of CHINA DEVELOPMENT. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and CHINA DEVELOPMENT.
Diversification Opportunities for GeneReach Biotechnology and CHINA DEVELOPMENT
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between GeneReach and CHINA is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and CHINA DEVELOPMENT FINANCIAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHINA DEVELOPMENT and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with CHINA DEVELOPMENT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHINA DEVELOPMENT has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and CHINA DEVELOPMENT go up and down completely randomly.
Pair Corralation between GeneReach Biotechnology and CHINA DEVELOPMENT
Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the CHINA DEVELOPMENT. In addition to that, GeneReach Biotechnology is 11.51 times more volatile than CHINA DEVELOPMENT FINANCIAL. It trades about -0.07 of its total potential returns per unit of risk. CHINA DEVELOPMENT FINANCIAL is currently generating about 0.24 per unit of volatility. If you would invest 789.00 in CHINA DEVELOPMENT FINANCIAL on October 30, 2024 and sell it today you would earn a total of 5.00 from holding CHINA DEVELOPMENT FINANCIAL or generate 0.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
GeneReach Biotechnology vs. CHINA DEVELOPMENT FINANCIAL
Performance |
Timeline |
GeneReach Biotechnology |
CHINA DEVELOPMENT |
GeneReach Biotechnology and CHINA DEVELOPMENT Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GeneReach Biotechnology and CHINA DEVELOPMENT
The main advantage of trading using opposite GeneReach Biotechnology and CHINA DEVELOPMENT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, CHINA DEVELOPMENT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHINA DEVELOPMENT will offset losses from the drop in CHINA DEVELOPMENT's long position.GeneReach Biotechnology vs. Oneness Biotech Co | GeneReach Biotechnology vs. EirGenix | GeneReach Biotechnology vs. Medigen Vaccine Biologics | GeneReach Biotechnology vs. OBI Pharma |
CHINA DEVELOPMENT vs. Tainet Communication System | CHINA DEVELOPMENT vs. Tong Hwa Synthetic Fiber | CHINA DEVELOPMENT vs. Johnson Chemical Pharmaceutical | CHINA DEVELOPMENT vs. Prime Oil Chemical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |